US Patent Issued to CMG Pharmaceutical on Sept. 23 for "Pyrimidinedione-based compounds as AXL, c-MET, and Mer inhibitors and methods of use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,207, issued on Sept. 23, was assigned to CMG Pharmaceutical Co. Ltd. (Seongnam, South Korea).

"Pyrimidinedione-based compounds as AXL, c-MET, and Mer inhibitors and methods of use thereof" was invented by Jin Sung Kim (Seoul, South Korea), Young Sang Kim (Goyang, South Korea), Sungmoo Kim (Seongnam, South Korea), Ju Hui Jeong (Seongnam, South Korea), Hyun Sook An (Seongnam, South Korea) and Soojeong Kim (Yongin, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an inhibitor of AXL, Mer, and/or c-Met of Formula (I) or a pharmaceutically acceptable salt thereof:in which R1, R2, R3, G, and Q are described herein. Further provided ...